Comparing Efficacy of Surgicel ® Application with Nasal Packing in Epistaxis

  • Yazar/lar Sözen, Tevfik
    Önay, Övsen
    Ceylan, Seyit Mehmet
  • Yayın Türü Makale
  • Yayın Tarihi 2019
  • DOI Numarası https://doi.org/10.25000/acem.489634
  • Dergi Adı Archives of Clinical and Experimental Medicine 4, ( 1 ), pp.33 - 36
  • Tek Biçim Adres http://hdl.handle.net/handle/20.500.12527/612

Aim: To evaluate the efficacy and tolerability of Surgicel ® application with transseptal suturing in epistaxis. Methods: Thirty-four patients who underwent therapy for epistaxis from Kiesselbach’s area, between January 2015 and August 2016, were retrospectively analyzed. As a treatment modality, anterior nasal packing (Merocel® tampon with airway) was inserted to 18 patients, and transseptal suturing combined with the Surgicel ® application was performed in 16 patients. The pain experienced during the procedure and compliance of the patients was evaluated using the NRS-11 morbidity scale that was administered during the control visits. Results: No significant difference was identified between the two groups regarding the efficacy of bleeding control. Transseptal suturing combined with the Surgicel ® application was tolerated better and had lower morbidity compared to nasal packing. Conclusion: This study showed that transseptal suturing with the Surgicel ® application is an effective and well-tolerated procedure in the treatment of anterior epistaxis.

Erişime Açık
Görüntülenme
1
20.05.2024 tarihinden bu yana
İndirme
1
20.05.2024 tarihinden bu yana
Son Erişim Tarihi
24 Mayıs 2024 11:08
Google Kontrol
Tıklayınız
Tam Metin
Tam Metin İndirmek için tıklayın Ön izleme
Detaylı Görünüm
ISSN
(dc.identifier.issn)
2564-6567
Haklar
(dc.rights)
info:eu-repo/semantics/openAccess
Eser Adı
(dc.title)
Comparing Efficacy of Surgicel ® Application with Nasal Packing in Epistaxis
Özet
(dc.description.abstract)
Aim: To evaluate the efficacy and tolerability of Surgicel ® application with transseptal suturing in epistaxis. Methods: Thirty-four patients who underwent therapy for epistaxis from Kiesselbach’s area, between January 2015 and August 2016, were retrospectively analyzed. As a treatment modality, anterior nasal packing (Merocel® tampon with airway) was inserted to 18 patients, and transseptal suturing combined with the Surgicel ® application was performed in 16 patients. The pain experienced during the procedure and compliance of the patients was evaluated using the NRS-11 morbidity scale that was administered during the control visits. Results: No significant difference was identified between the two groups regarding the efficacy of bleeding control. Transseptal suturing combined with the Surgicel ® application was tolerated better and had lower morbidity compared to nasal packing. Conclusion: This study showed that transseptal suturing with the Surgicel ® application is an effective and well-tolerated procedure in the treatment of anterior epistaxis.
Yayın Tarihi
(dc.date.issued)
2019
Kayıt Giriş Tarihi
(dc.date.accessioned)
2021-12-16T16:05:44Z
Açık Erişim tarihi
(dc.date.available)
2021-12-16T16:05:44Z
Yayın Dili
(dc.language.iso)
English
Yayının ilk Sayfa Sayısı
(dc.identifier.startpage)
33
Yayının son sayfa sayısı
(dc.identifier.endpage)
36
Dergi Adı
(dc.relation.journal)
Archives of Clinical and Experimental Medicine
Dergi Sayısı
(dc.identifier.issue)
1
Dergi Cilt
(dc.identifier.volume)
4
Yayın Türü
(dc.type)
Makale
Yazar/lar
(dc.contributor.author)
Sözen, Tevfik
Yazar/lar
(dc.contributor.author)
Önay, Övsen
Yazar/lar
(dc.contributor.author)
Ceylan, Seyit Mehmet
Tek Biçim Adres
(dc.identifier.uri)
http://hdl.handle.net/handle/20.500.12527/612
DOI Numarası
(dc.identifier.doi)
https://doi.org/10.25000/acem.489634
Kurum Yazar/lar
(dc.contributor.sankoauthor)
Seyit Mehmet Ceylan
Atıf Dizini
(dc.source.database)
TRDizin
Analizler
Yayın Görüntülenme
Yayın Görüntülenme
Erişilen ülkeler
Erişilen şehirler
6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve cerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.
Tamam

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms